Introduction
The pseudotyping of lentiviral vectors with envelope proteins from other viruses provides a powerful means for directing gene transfer to desired tissue targets. The G envelope glycoprotein from vesicular stomatitis virus (VSV-G) is widely used for this purpose, since it is highly efficient at pseudotyping retroviral and lentiviral vectors for targeting gene transfer to a broad range of cell and tissue types. [1] [2] [3] However, some tissues and cells are refractory to vectors pseudotyped with VSV-G. For example, gene transfer to the apical membrane of some polarized epithelia, including polarized airway epithelia, are refractory to entry by VSV-G pseudotyped vectors. [4] [5] [6] [7] To overcome this limitation, recent studies have investigated the use of envelope proteins from filoviruses, paramyxoviruses, and orthomyxoviruses. [8] [9] [10] [11] Although some of these studies have shown promise, vector titers with these envelopes have been much lower than titers obtained using VSV-G pseudotyping.
The goal of this study was to investigate experimental parameters that contribute to efficient pseudotyping of lentiviral vectors by influenza hemagglutinin (HA) from fowl plague virus (FPV, H7/Rostock). FPV HA was chosen because of previous studies showing its utility in pseudotyping retrovirus vectors. [12] [13] [14] Specifically, we determined the effects of other influenza virus membrane proteins on the efficiency of HA pseudotyping. FPV, like other influenza A viruses, encodes three envelope proteins whose roles in virus replication have been well characterized. HA is responsible for binding to sialic acid receptors on the cell surface and also mediates fusion of viral membranes and endosomal membranes after endocytosis. 15, 16 HA is synthesized as a polyprotein and is activated by cleavage to generate HA1 and HA2 subunits. The proteolytic cleavage site of HA in certain pathogenic avian strains of influenza, such as FPV, is a multi-basic domain recognized by furin or furin-like proteases within the trans-Golgi network (TGN). Cleavage of the HA precursor exposes the fusion domain on the HA2 subunit that fuses with endosomal membranes after a low pH-activated conformational change in newly infected cells. 17 A second influenza virus envelope protein, M2, a spliced transcript of RNA segment 7, forms a nonglycosylated homotetrameric proton channel. M2 regulates the potentiation of membrane fusion by buffering intracellular compartments both in late and early stages of viral replication. Late in infection during virus production, M2 acts to raise the pH during transit through the TGN and prevents the low pH-induced inactivation of co-transported HA. 18 Early in infection of new cells after endocytic uptake of viral particles, activation of M2 proton channel activity leads to acidification of the interior of the virion during the uncoating process. 19 This results in the release of subviral ribonucleoprotein from the endosome where it traffics to the nucleus for RNA replication.
Influenza neuraminidase (NA), the third membrane protein, is a tetrameric glycoprotein responsible for releasing virions from surface sialic acid on producer cells and may also have a role in promoting access to target cells in the airways. 20, 21 In this study, we investigated the effect of expressing influenza M2 and NA cDNAs on pseudotyping lentiviral vectors with FPV HA. We found that expression of viral cDNAs for M2 and NA in lentiviral producer cells significantly increases the titers of HA-pseudotyped vectors. The HA-pseudotyped vectors were able to efficiently transduce cells using receptors located on the apical membrane of polarized airway epithelial cells, and thus, such vectors have a tropism distinct from VSV-G-pseudotyped vectors.
Results

M2 augments HA pseudotyping of lentiviral vectors
To investigate the expression of FPV HA at the producer cell surface, 293T cells were transfected with an FPV HA expression vector either in the presence or absence of FPV M2. At 48 h after transfection, cells were fixed but not permeablized, and probed with a polyclonal antibody raised against influenza subtype H7 (Figure 1 ). There was an abundance of positive antibody staining on the surface of cells transfected with both FPV HA and M2, but little or no staining on those cells transfected with FPV HA alone. This suggests that M2 is necessary for efficient expression of HA at the cell surface of 293T cells.
To determine whether FPV M2 expression would affect production of HA-pseudotyped equine infectious anemia virus (EIAV)-based lentiviral vectors, an FPV HA-pseudotyped lacZ-containing vector, SIN6.1CZW, 3 was generated by transient transfection of 293T cells in the presence of increasing amounts of a FPV M2 expression plasmid. Vector-producing cells were treated with bacterial neuraminidase to release virions into the medium and the relative efficiency of vector production was determined (Figure 2a) . Vector production was enhanced by M2 in a dose-dependent manner. At the highest dose (5 mg) of M2 plasmid, a 30-fold increase in vector production was observed compared to transfection reactions lacking M2. In parallel transfection reactions, it was found that M2 expression did not enhance production of VSV-G-pseudotyped vectors (Figure 2a) . Thus, the effect of FPV M2 on augmentation of FPV HA pseudotyping is unlikely to be because of non-specific effects on vector production.
Synergy of M2 expression and neuraminidase treatment
Bacterial NA has been previously used to facilitate the release of influenza virions from sialic acid residues at the producer cell surface. 20, 22 We investigated the effect of NA treatment on production of HA-pseudotyped lentiviral vectors. In the absence of NA treatment, only a low level of vector was produced regardless of M2 expression (Figure 2b ). NA treatment alone increased vector production approximately 25-fold. Both NA treatment and M2 expression resulted in a 750-fold increase in vector production, to titers of about 10 5 infectious units (IU)/ml (Figure 2b ). Taken together, the results in Figures 1 and 2 are consistent with a model where FPV M2 is important for increasing the amount of HA into virions assembling at the cell surface, while NA is crucial for the release of virions from the cell surface into the extracellular medium. We compared bacterial NA treatment of cells to influenza NA treatment supplied to the cells in the form of an influenza NA cDNA expression vector (Figure 3 ). Optimal vector production using bacterial neuraminidase was observed when vector-producing cells were treated with 7 mU neuraminidase/ml serum-free cell culture medium (Figure 3a) . Full-length influenza NA cDNA, prepared by RT-PCR amplification of the NA gene from A/PR/8/34 influenza virus (H1N1), was expressed from a plasmid vector (pEF-NA) during vector production. Expression of influenza NA cDNA led to a dose-dependent increase in vector production ( Figure  3b ). At the highest levels of NA cDNA tested, approximately twofold greater transduction efficiencies were obtained compared to the optimal level of bacterial NA used to treat producer cells.
Amantadine inhibits M2 augmentation of HA pseudotyping
To further characterize the mechanism of FPV M2 action on HA pseudotyping, the effect of amantadine on vector production was tested. Amantadine has been shown to affect influenza virus replication by specifically inhibiting the ion channel activity of influenza M2. 23 Adding increasing amounts of amantadine to vector-producing cells resulted in a potent dose-dependent effect on vector production ( Figure 4 ). Amantadine inhibited M2 augmented vector product by 70% at a concentration of 5 mM. Similar concentrations have been shown to effectively inhibit influenza virus replication in cell culture. 24 The effect of amantadine on an M2 mutant carrying a single amino-acid change, I27S, was determined. The I27S mutation has been shown to affect the interaction of amantadine with the M2 protein, resulting in amantadine-resistant M2 ion channel activity. 25 Compared to wild-type M2, EIAV vector production in cells expressing the I27S M2 was significantly more resistant to inhibition by amantadine ( Figure 4 ). These results suggest that the ion channel activity of M2 is critical for M2 augmentation of HA pseudotyping. In control experiments, the effect of amantadine on VSV-G pseudotyping was tested. It was found that for concentrations in the range of 5-170 mM, amantadine did not affect pseudotyping of SIN6.1CZW by VSV-G ( Figure 4 ).
To determine if M2 channel activity was important in the gene transfer step, vectors were produced in the absence of amantadine and cells were then transduced in the presence of increasing amounts of amantadine. It was found that inhibition of transduction was only observed at high concentrations (4170 mM) of amantadine (data not shown). Thus, the early steps of infection by M2 augmented HA-pseudotyped lentiviruses, unlike the early steps of influenza virus replication, are not affected by amantadine. These results suggest that the primary effect of M2 ion channel activity on HA pseudotyping of EIAV vectors is on vector production.
Host range of HA-pseudotyped EIAV vectors
The HA-pseudotyped SIN6.1CZW vector produced in cells expressing influenza M2 and NA cDNAs was used to measure the ability of virus pseudotyped with FPV HA to transduce a panel of mammalian and avian cell lines. The FPV HA-pseudotyped vectors transduced cells derived from primary chicken embryo fibroblasts and mammalian cell lines derived from humans, rodents, horses and dogs (Table 1) . No obvious species preference was observed. Compared to VSV-G-pseudotyped virus, FPV HA infectivity was variable among cell types with FPV HA:VSV-G infectivity ratios ranging from B0.01 (Rat208F) to B0.3 (CFT1). The highest titers of HA- 
M2 augmentation of HA-pseudotyped MLV and HIV-1 vectors
To determine if M2 augmentation of pseudotyping was limited to equine lentiviral vectors or also applied to other retroviruses, the requirements for FPV HA pseudotyping of vectors derived from murine leukemia virus (MLV) and HIV-1 were determined ( Table 2 ). The results indicated that HA-pseudotyped vector production was enhanced by M2 for MLV and HIV-1, although the magnitude (5-10-fold) was less than that typically seen for augmentation of EIAV vectors (20-30-fold). The titers obtained for FPV HA pseudotyping of EIAV and HIV lentiviral vectors in the presence of FPV HA and NA were similar (B3-4 Â 10 5 IU/ml), whereas the titers obtained for pseudotyping the MLV vector HIT-SIN-CZ were significantly higher at 4 Â 10 6 IU/ml.
Gene transfer to polarized primary cultures of murine tracheal cells
To determine if lentiviral vectors pseudotyped with influenza virus envelope proteins have a preference for apical or basolateral entry into polarized epithelia, we compared transduction with VSV-G-pseudoyped vectors previously shown to infect only basolaterally in mouse tracheas in vivo. 5 Well-differentiated cultures of polarized tracheal epithelia were transduced with a vector cocktail of FPV HA-pseudotyped EIAV expressing EGFP and VSV-G-pseudotyped EIAV expressing DsRed2. The vector cocktail was applied to either the apical or basolateral surface at an MOI B1 for each virus. The HApseudotyped vectors had been produced using optimal levels of M2 and NA-expressing plasmids as described in Figures 2 and 3 . In the apically applied vector cocktail, only EGFP-positive cells were observed indicating that only FPV HA-pseudotyped virus was capable of transduction via the apical membrane ( Figure 5 ). When applied to the basolateral surface, both FPV HA and VSV-G pseudotypes were capable of transduction, although the level of transduction of the FPV HApseudotyped vector appeared less compared to apical application. This may reflect an asymmetry in receptor levels for HA-pseudotyped vectors since the difference in transduction between the two sides was greater than that expected from the barrier effect of the collagencoated membrane of the Transwell-col structure. 26 In cultures transduced apically, up to 30% of cells were transduced with the HA-pseudotyped vector as determined by morphometric analysis, whereas basolateral application of virus with the same titer resulted in o5% transduction. In these experiments, the efficiency of FPV HA-mediated apical transduction was found to be similar to VSV-G-mediated basolateral transduction. To show that FPV HA-mediated apical transduction was specific to sialic acid presentation on the apical surface of these cells, we pretreated well-differentiated mouse tracheal cultures with bacterial NA prior to infection at a viral dose of 5 Â 10 5 IU/well. For NA-treated cultures, transduction was barely detectable compared to widespread transduction in untreated cultures ( Figure 6 , panels a and b). These data indicate that FPV HApseudotyped lentivirus infects polarized mouse tracheal cultures via sialic acid-containing receptors on the apical surface.
To determine if both ciliated and non-ciliated cells within the epithelial cell monolayer were expressing EGFP following apically applied vector, we used a rabbit anti-EGFP antibody to detect EGFP protein expression in formaldehyde-fixed, histologic sections. Ciliated cells were identified by co-immunostaining with a mouse anti-bIV-tubulin antibody. 27, 28 An example of a cell co-staining with both antibodies is shown in Figure 6c . Of 91 cells identified as EGFP positive from randomly Vector titers are the mean7s.e. of titers from three independent replicates from common lots of the SIN6.1CZW vector pseudotyped with HA or VSV-G. 
In vivo delivery of HA-pseudotyped EIAV vectors to mouse trachea
Direct in vivo delivery to the trachea of mice was tested using the double tracheotomy technique for delivery to the tracheas of anesthetized mice. 5, 7 For these experiments, the FPV HA-pseudotyped EIAV SIN6.1CZW vector was produced using optimal levels of M2 and NA-expressing plasmids as determined in Figures 2 and  3 , and concentrated by high-speed centrifugation (5000 g, 20 h) to a titer of 2 Â 10 8 IU/ml. The vector was instilled into the tracheas of 3-week-old mice (n ¼ 4). The mice were not subjected to treatments to injure or disrupt the integrity of the tracheal epithelium. Animals were killed 96 h after gene delivery and excised tracheas were stained for lacZ reporter gene expression with X-gal. It was found that significant transduction had occurred in the tracheas of animals inoculated with the HA-pseudotyped EIAV SIN6.1CZW vector (Figure 7) . In control experiments, animals were instilled with a 20-fold higher dose (20 ml of 4 Â 10 9 IU/ml) of the EIAV SIN6.1CZW vector pseudotyped with the VSV-G envelope. With VSV-G-pseudotyped vectors, very little gene delivery occurred to the airway epithelium in the absence of injury (Figure 7) , as observed previously using HIV-1-based Figure 5 EIAV pseudotyped with FPV HA transduces cultures of well-differentiated murine tracheal epithelia primarily via the apical surface, whereas VSV-G-pseudotyped EIAV transduction is only basolateral. Purified epithelial cells from mouse trachea were cultured on permeable membranes until the epithelium became well differentiated (resistance 4800 O cm 2 ). A vector cocktail was prepared containing both FPV HA-pseudotyped EIAV expressing EGFP and VSV-G-pseudotyped EIAV expressing DsRed2 at a dose of 5 Â 10 5 IU for each vector. The HA-pseudotyped vectors had been produced in transfection reactions using the optimal amounts of M2 and NA cDNAs as determined in Figures 2a and 3b . The EGFP/ DsRed2 vector cocktail was applied to the apical membrane or to the basolateral membrane surface of parallel cultures. Enface fluorescence images were captured 7 days post-infection. 
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vectors. 5 Thus, the FPV HA-pseudotyped virus is more efficient at delivering genes to uninjured mouse trachea than VSV-G-pseudotyped virus.
Discussion
Efficient pseudotyping of lentiviral vectors with FPV HA is complex since functions of two other influenza virus integral membrane proteins must be provided. Although previous studies have used bacterial NA to treat cells producing FPV HA-pseudotyped lentiviral vectors, the possible utility of M2 to enhance pseudotyping has not been reported. 14 The studies presented in this report emphasize the importance of co-expressing the influenza M2 protein in producer cells in order to achieve efficient FPV HA pseudotyping of retroviral and lentiviral vectors. Expression of M2 led to a 10-30-fold increase in titers of HA-pseudotyped lentiviral vectors and about a fivefold increase in titers of MLV retroviral vectors.
The mechanism for M2 enhancement of HA pseudotyping was investigated and the results are in line with previous studies showing the importance of the ionchannel activity of FPV M2 in enhancing the accumulation of FPV HA at the cell surface in FPV-infected cells. 29 M2, however, was not sufficient to enhance HA pseudotyping and efficient vector production required NA activity supplied either by enzymatic treatment of producer cells with bacterial NA or by co-expressing influenza NA cDNA. These results are consistent with the well-documented role of NA to release influenza virus particles from the cell surface. 20 Thus, the roles that M2 and NA play in production of HA-pseudotyped lentiviral vectors are similar to their natural roles in influenza virus production. However, although M2 has an amantadine-sensitive role during early influenza infection, 19, 30 we were unable to obtain evidence that M2 functions during HA-pseudotyped lentiviral vector infection of target cells (data not shown). This may reflect mechanistic differences of uncoating between EIAV and FPV early after infection, although it should be noted that we did not determine if M2 is incorporated into lentiviral vector particles.
Purified bacterial NA is expensive, so we cloned the A/PR/8/34 (H1N1) NA cDNA into an expression plasmid for co-transfection experiments. This NA was chosen because it has been shown to have a wide ranging sialic acid cleavage activity. 31, 32 As with M2 expression, NA expression from a plasmid expression vector resulted in a dose-dependent increase in end point titer. Importantly, expressing NA from plasmid DNA led to a twofold increase in titer over that achieved using treatment with purified bacterial enzyme (Figure 3) .
Although the increase in titer with increased levels of transfected M2 and NA expression vectors did not plateau (Figures 2a and 3b) , we started to see toxicity in producer cells that we attributed to the concentration of DNA/calcium phosphate co-precipitant necessary for transfection of such a high quantity of DNA. Consequently, plasmid load limited the efficiency of transfection rather than expression of transgene. In future experiments, this could be addressed by optimizing levels of NA and M2 expression.
EIAV vectors, based on a similar backbone, have previously been pseudotyped successfully with a number of envelope proteins including VSV-G, Rabies, Mokola and LCMV envelopes. 3, 33, 34 To determine if M2 augmentation was important to HA pseudotyping of other lentiviral and retroviral vectors, we tested HIV-1 and MLV-based vectors. Both vector systems showed the M2 augmentation of HA pseudotyping seen with EIAV (Table 2) . MLV titers were significantly higher than those for both lentiviruses but this is consistent with observations with VSV-G (data not shown). We conclude that FPV HA pseudotyping can be applied to a number of vector systems and vectors with this pseudotype have a broad host range.
Previous studies have shown that VSV-G-pseudotyped lentiviral vectors are unable to transduce the apical side of uninjured polarized airway epithelia when applied via the airway lumen. [4] [5] [6] [7] Using cultured murine tracheal epithelial (MTE) cells, we found that FPV HApseudotyped lentiviral vectors are capable of utilizing Figure 7 Gene transfer to uninjured mouse trachea with FPV HA-or VSV-G-pseudotyped EIAV LacZ vectors. The HA-pseudotyped EIAV SIN6.1CZW vector was produced in transfection reactions using the optimal amounts of M2 and NA cDNAs as determined in Figures 2a and  3b and concentrated by ultracentrifugation. Double tracheotomies were performed on 3-week-old anesthetized mice (n ¼ 3). Approximately 20 ml of the HA-pseudotyped vector (4 Â 10 6 infectious units) or VSV-G-pseudotyped vector (8 Â 10 7 infectious units) was instilled into the proximal tracheostomy. PBS was instilled into sham-infected controls. The vector dwell time was 2 h. The animals were killed 96 h postinfection. Tracheas were removed and stained with X-Gal for histochemical analysis. The top panels show en face views of an X-Gal-stained control (PBS) and vector treated tracheas opened longitudinally. The bottom panels show representative histologic sections of tracheas counterstained with nuclear fast red (magnification, Â 50) taken from the control and vector instilled tracheas.
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T McKay et al receptors on the apical membrane surface. The welldifferentiated MTE culture model that we used 35 has not extensively been used for gene transfer studies, but we found it useful for investigating the polarity (apical vs basolateral) of transduction, for confirming that HA pseudotype transduction was mediated by sialic acid binding, and for determining if ciliated cells could be transduced. Our findings with regards to infection polarity by HA-and VSV-G-pseudotyped vectors are consistent with the known preferences of the originating pathogens, influenza and VSV. 36, 37 Both ciliated and non-ciliated cells could be transduced with FPV HApseudotyped vectors; however, there appeared to be a preference for transduction of ciliated cells. A similar preference for infection of ciliated cells of cultured human airway epithelia has recently been shown for several avian influenza viruses, including the Rostock strain of FPV. 37 To assess whether FPV HA-pseudotyped EIAV is an appropriate vector for direct in vivo gene transfer, concentrated vectors were instilled into the tracheal lumen of 6-week-old mice and compared to transduction with vectors pseudotyped with VSV-G. Very little transduction was observed in VSV-G-pseudotyped, EIAV-treated animals, consistent with previous studies using VSV-G-pseudotyped lentiviral vectors administered to the tracheal lumen of uninjured animals. 4, 6, 7, 38 In contrast, tracheas showed widespread expression of the lacZ reporter gene in all animals infected with HApseudotyped EIAV. Histological analysis confirmed that transduction was largely confined to the columnar epithelium. We suggest that lentiviral vectors pseudotyped with influenza HA may be useful for gene transfer applications involving the conducting airways.
Materials and methods
Cell culture
Human embryonic kidney 293T cells, NIH-3T3 fibroblasts, rat 208F fibroblasts and human osteosarcoma HOS cells were maintained in Dulbecco's modified Eagle's medium (DMEM-H) supplemented with 10% fetal bovine serum (FBS) (both Gibco Life Technologies). Canine fibrosarcoma D17 cells and equine dermal fibroblast NBL6 cells were maintained in MEM (Gibco Life Technologies) supplemented with non-essential amino acids (Gibco Life Technologies). Chicken embryo fibroblasts and human tracheal CFT1 epithelial cells were grown as described previously. 39, 40 Isolation and culture of murine trachea epithelia Epithelial cells from mouse trachea were isolated and maintained as described by You et al. 35 Briefly, whole tracheas were removed from 3-to 6-week-old C57BL/6 mice and bathed in ice-cold Ham's F-12 medium containing 100 U/ml penicillin and 100 mg/ml streptomycin. Muscle and vascular tissue was dissected away and tracheas cut longitudinally and washed three times in Ham's F-12 before incubation in 1.5 mg/ml Pronase (Roche Molecular Biochemicals) overnight. Tracheas were washed twice in Ham's F-12 medium, then discarded. Medium was pooled and FBS added to a final concentration of 10%. Cells were pelleted at 400 g for 10 min at 41C. After suspension in Ham's F-12 containing antibiotic and 0.5 mg/ml crude pancreatic DNase I and 10 mg/ml bovine serum albumin (both Sigma-Aldrich), cells were incubated on ice for 5 min, then pelleted. The cell pellet was suspended in MTEC Basic medium (1:1 DMEM/Ham's F-12, 15 mM HEPES, 3.6 mM sodium bicarbonate, 4 mM L-glutamine, 100 U/ml penicillin, 100 mg streptomycin) supplemented with 0.25 mg/ml fungizone and 40 mg/ml gentamycin and incubated on tissue culture plates at 371C, 5% CO 2 for 4 h to remove fibroblasts by adherence. Non-adherent epithelial cells were collected, pelleted and suspended in MTEC Basic medium supplemented with 10 mg/ml insulin, 5 mg/ml transferrin, 0.1 mg/ml cholera toxin, 25 ng/ml epidermal growth factor, 30 mg/ml bovine pituitary extract, 0.01 mM retinoic acid and 5% FBS (MTEC Plus). Cells were plated onto Transwell Col inserts (0.4 mM, Corning-Costar) and fed from the upper and lower chamber with MTEC Plus until the epithelia formed a liquid tight polarized epithelium which was then fed from the lower chamber only. Cultures were considered well differentiated based on obvious presence of cilia, formation of a polarized cell layer demonstrated by development of a transmembrane resistance 4800 ohm cm 2 , and exclusion of media from the upper chamber.
Plasmid constructs
The plasmid expressing FPV HA (pFPV-HA, H7/Rostock strain) was obtained from F-L Cosset. 12 The pCB6-M2 plasmid expressing Rostock M2 was obtained from Ora Weisz. 41 The I27S mutant M2 was created by overlap PCR mutagenesis 42 from the plasmid pCB6-M2 using the following primers sets: external primers; ctctagaggatc catgagtc and cccgggatccttactcc, internal primers; ccctctcagtattgccgc and gcggcaatactgagaggg. The influenza NA coding sequence was generated by RT-PCR from an A/PR/8/34 influenza virus (H1N1) isolate obtained from the ATCC using the set of universal primers specific for gene segments of influenza A viruses. 43 The PCR product was cloned into the pEF6/V5-His-TOPO mammalian expression vector (Invitrogen). The pCI-VSV-G plasmid expressing vesicular stomatitis virus envelope glycoprotein has been previously described. 5 The EIAV packaging plasmid pEV53B has also been described, 44 as has the plasmid form of the SIN EIAV gene transfer vector, pSIN6.1CW. 3 A reporter gene (either Escherichia coli lacZ, EGFP) or DsRed2 (Clontech) gene was cloned immediately downstream of the internal CMV promoter creating the plasmid form of the SIN6.1CZW, SIN6.1-CEGFPW and SIN6.1DsRedW vector, respectively. The HIV-1 pLP1 Gag-Pol and pLP2 Rev expression vectors from the ViraPower Lentiviral Expression System (Invitrogen) were used to produce the HIV-LacZ vector, Lenti6/V5-GW/lacZ (Invitrogen). The production of the murine leukemia virus (MLV)-based lacZ vector (HIT-SIN CZ) has been previously described. 5 Bacterial NA treatment Bacterial NA (7 mU/ml) from Vibrio cholera (Calbiochem) was applied to 293T vector producer cells for 18 h in serum-free growth medium in the presence of 10 mM sodium butyrate. 45 To remove sialic acid from welldifferentiated mouse cultures, NA was applied to Transwell Col inserts for 4 h at a concentration of 
Immunofluorescence analysis
For immunoflourescent detection of FPV HA expression, 293T cells were plated on poly-L-lysine-coated glass coverslips at 1 Â 10 5 cells/10-mm coverslips 24 h prior to transfection. Cells were transfected with 1 mg pFPV-HA with or without 3 mg pCB6-M2 and incubated at 371C, 5% CO 2 for 48 h before being fixed with 4% paraformaldehyde for 20 min at 41C. Fixed cells were washed repeatedly with PBS, blocked with 3% BSA in PBS and incubated with 1% BSA in PBS containing a 1/1000 dilution of H7N2 antiserum raised in sheep (NIBSC, Herts, UK) for 1 h. After three washes with 1% BSA in PBS, FITC-conjugated rabbit anti-sheep IgG was added at a dilution of 1/2000 in 1% BSA in PBS and incubated for 1 h. Following three further washes with 1% BSA in PBS, coverslips were mounted on glass slides using Vectashield mounting medium (Vector Laboratories) and analyzed for cellular HA expression using a Leica DMIRB inverted fluorescent/DIC microscope. Co-immunostaining for EGFP and bIV-tubulin in deparaffinized tissue sections was carried out as described previously.
27,28
Preparation of retroviral and lentiviral vectors
Recombinant retroviral and lentiviral stocks were generated using transient plasmid transfection of 293T cells as previously described. 5 Briefly, 2 Â 10 6 293T cells were plated on 10-cm tissue culture dishes 16 h prior to transfection. Cells were transfected by standard calcium phosphate technique using 15 mg of vector and Gag-Pol expressing plasmids, whereas 9 mg of envelope expressing plasmid was used. After 24 h, cells were replenished with medium containing 10 mM sodium butyrate and supernatant containing viral vectors was harvested after another 24 h incubation. Virus was filtered through a 0.2 mm membrane and used for transduction directly or subjected to ultracentrifugation at 80 000 g (Beckman SW-28 rotor) for 2 h, or for 6000 g for 20 h (Sorvall H6000A rotor). Virus pellets were suspended in vector formulation buffer (20 mM Tris (pH 7.0), 37 mM NaCl and 40 mg/ml lactose) and stored at À801C.
Amantadine treatment of 293T producer cells
293T producer cells were plated and transfected as described in the previous section. Amantadine was added to the medium containing sodium butyrate and bacterial NA and incubated 24 h prior to vector collection.
Vector titering and transduction efficiency
Viral stocks were titered by serial dilution on 293T cells. Cells were plated at 2 Â 10 5 cells/well in 12-well dishes 18 h prior to infection. Serial dilutions of viral stocks were incubated with 8 mg/ml polybrene for 20 min, then applied to cells for 2 h before replenishing with fresh growth medium. After 48 h, the percentage of transduced cells was determined using a hemocytometerbased assay as described previously. 44 In some experiments, the relative transduction efficiency of lacZcontaining vectors was determined by measuring b-gal activity in lysates of transduced cells using the GalactoLight Plus kit (Tropix).
Gene transfer to mouse trachea in vivo
Lentiviral vectors were applied to the apical surface of tracheal epithelia of mice as previously described by Johnson et al. 5 Tracheas of 6-week-old anesthetized mice were surgically exposed, and a distal tracheotomy was made near the carina for ventilation (breathing) and a proximal tracheotomy was made for vector instillation at the first cartilaginous tracheal ring. The region between the two tracheotomies was filled with 20 ml vector in vector formulation buffer for 2 h. The animals were repaired and killed 96 h post-infection; their tracheas were removed and stained with 5-bromo-4-chloro-3-indolyl-D-galactopyranoside (X-Gal) for histochemical analysis.
X-Gal histochemistry
Cultured cells were fixed in 0.5% glutaraldehyde and stained with X-Gal for 2 h as previously described. 46 Excised tracheas were fixed for 2 h in 4% paraformaldehyde/0.2% glutaraldehyde at 41C, stained in X-Gal solution for 6 h and post-fixed in Omnifix II. Images of intact tracheas were captured with a cooled CCD camera. For sectioning, tracheas were embedded in paraffin and longitudinal sections (8 mm thick) at 50-to 100-mm levels were taken, mounted on slides, and counterstained with nuclear fast red. Histological sections were used to confirm localization of staining to airway.
